glp 1 and substance use disorder IUPHAR review – Glucagon-like peptide-1 (GLP-1) disorders: An emerging pharmacotherapeutic target Clinical evidence has long suggested

Referral to registered dietitians specializing in weight management, behavioral psychology for eating disorder assessment, or structured weight management programs may address non-pharmacological barriers

We want to emphasize that although these factors can be used to guide clinical decisions, they may not have a causal relationship with the response to GLP-1 M

Lifestyle habits to support results Semaglutide works best alongside lifestyle changes

Marine omega-3 fatty acids prevent myocardial insulin resistance and metabolic remodeling as induced experimentally by high insulin exposure

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

Desai S, Friedman A